We assayed viral replication in activated CD8-depleted PBMC in the presence and absence of 5,000 U/ml of IFN-α, which was added 24 hours prior to infection in order to maximally inhibit viral replication, as described previously [17]. The gene discussed is CD8A; the disease is infection.